Advanced Neuroimaging & Artificial Intelligence

Technologies for the Rapid Diagnosis of Stroke, Oncology, and Neurodegenerative Diseases

Kaster Medical Technology, the exclusive distributor for Italy of Cercare Medical, offers advanced imaging solutions based on proprietary algorithms and artificial intelligence for the rapid and accurate diagnosis of major cerebrovascular and neuro-oncological diseases.

The Cercare CT/MR Stroke, Cercare CT/MR Stroke Advanced, and Cercare MR Neuro Advanced platforms enable clinicians to obtain comprehensive information on cerebral perfusion, tissue viability, and metabolic and vascular characteristics, improving treatment decisions and time to intervention.

STROKE AREA – ADVANCED STROKE DIAGNOSIS

Acute ischemic stroke is a leading cause of global morbidity and requires extremely rapid assessment. Imaging quality and the ability to distinguish the infarct core from the ischemic penumbra are critical for deciding on treatment (thrombolysis, mechanical thrombectomy). Clinical challenges of imaging in stroke
  • Need for accurate estimation of the ischemic core and hypoperfused area.
  • Difficulty in automatically and reliably quantifying lesions.
  • Complexity of CT/MRI protocols in unstable patients.
  • Rapid time required for therapeutic decision-making.

THE VASCULAR MODEL: A NEW STANDARD OF EVALUATION

The Vascular Model (VM) developed by Cercare Medical is a key component of all Stroke solutions.

Compared to traditional models, the VM offers:

  • clearer visualization of hypoperfused areas,
  • better correlation with final infarction,
  • greater consistency with the patient's actual neurological deficits.
Metabolic Biomarkers
  • OEF Fractional Oxygen Extraction Rate.
  • CMRO₂ Metabolic Oxygen Consumption Rate.
These markers allow for more accurate mapping of tumor aggressiveness, facilitate biopsy site selection, and aid in the differential diagnosis between high- and low-grade tumors.

ONCOLOGY - Advanced Metabolic and Perfusion Imaging

In brain cancer, accurate lesion characterization is essential to determine aggressiveness, treatment, and prognosis.

Challenges of Oncology Imaging

  • Difficulty distinguishing tumor progression from pseudoprogression.
  • Need for a combined vascular and metabolic assessment.
  • Traditional parameters are often insufficient.

PROPRIETARY BIOMARKERS FOR NEURO-ONCOLOGY

Vascular Biomarkers
  • CTH Capillary Transit Time Heterogeneity.
  • COV Microvascular Coefficient of Variance.
  • Leakage Blood-Brain Barrier Integrity.

NEURODEGENERATIVE AND NEUROVASCULAR DISEASES

Automated perfusion solutions are also applicable to chronic conditions such as:

  • Alzheimer's
  • Parkinson's
  • Moyamoya disease
  • Traumatic brain injury
  • Cerebral small vessel disease
These diseases require high-precision perfusion maps to monitor progression, optimize treatment, and assess therapeutic response.

Photo Gallery

Congresses

AIRN

ainr.it/

WSC (world stroke congress)

worldstrokecongress.org/

SIRM

areasoci.sirm.org/corsi_congressi

⁠ISA-AII

isa-aii.com/

ESMINT

www.esmint.eu/congress/